HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation CyclophosphamideLeo Luznik, Ephraim J. Fuchs, Paul V. O’Donnell et al.|Biology of Blood and Marrow Transplantation|2008Cited by 1.9k
Hepatic Veno-Occlusive Disease following Stem Cell Transplantation: Incidence, Clinical Course, and OutcomeJason Coppell, Dietger Niederwieser, Joseph H. Antin et al.|Biology of Blood and Marrow Transplantation|2009Cited by 595
HLA-Haploidentical Donor Lymphocyte Infusions for Patients with Relapsed Hematologic Malignancies after Related HLA-Haploidentical Bone Marrow TransplantationAmer M. Zeidan, Javier Bolaños‐Meade, Patrick M. Forde et al.|Biology of Blood and Marrow Transplantation|2013Cited by 113
Assessment of Environments for Mars Science Laboratory Entry, Descent, and Surface OperationsA. R. Vasavada, Paul Withers, Allen Chen et al.|Space Science Reviews|2012Cited by 78
Alternative-Donor Hematopoietic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide for Nonmalignant DisordersOrly R. Klein, Heather J. Symons, Allen Chen et al.|Biology of Blood and Marrow Transplantation|2016Cited by 76